Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Dynamics of Leukemia Stem-like Cell Extinction in Acute Promyelocytic Leukemia
Werner, Benjamin , Gallagher, Robert E. , Paietta, Elisabeth , Litzow, Mark R. , Tallman, Martin S. , Wiernik, Peter H. , Slack, James L., Sun, Zhuoxin , Traulsen, Arne , Dingli, David , Willman, Cheryl L. , Dingli, David

Cancer Research | August 1, 2014 | Volume: 74 | Issue: 19 | Pages: 5386-5396

10.1158/0008-5472.can-14-1210 | PMID 25082816 Get It

Abstract Many tumors are believed to be maintained by a small number of cancer stem–like cells, where cure is thought to require eradication of this cell population. In this study, we investigated the dynamics of acute promyelocytic leukemia (APL) before and during therapy with regard to disease initiation, progression, and therapeutic response. This investigation used a mathematical model of hematopoiesis and a dataset derived from the North American Intergroup Study INT0129. The known phenotypic constraints of APL could be explained by a combination of differentiation blockade of PML–RARα–positive cells and suppression of normal hematopoiesis. All-trans retinoic acid (ATRA) neutralizes the differentiation block and decreases the proliferation rate of leukemic stem cells in vivo. Prolonged ATRA treatment after chemotherapy can cure patients with APL by eliminating the stem-like cell population over the course of approximately one year. To our knowledge, this study offers the first estimate of the average duration of therapy that is required to eliminate stem-like cancer cells from a human tumor, with the potential for the refinement of treatment strategies to better manage human malignancy. Cancer Res; 74(19); 5386–96. ©2014 AACR.
Mayo Clinic Gastrointestinal Imaging Review
Johnson, D.

No container title available | August 1, 2014 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/med/9780199862153.001.0001 Get It

Abstract This resource provides an atlas of common abnormalities that affect the gastrointestinal tract and includes all imaging modalities used within GI radiology, as well as plain radiographs, fluoroscopy, ultrasound, CT, MR, angiography, and nuclear medicine. Focusing solely on adult conditions, it features 13 chapters covering a separate organ within the gastrointestinal system and a final exam chapter reviewing all chapter content. Each organ-focused chapter is subdivided into sections related to diseases or findings of that organ. Large, high-quality images are presented so that they can be reviewed as unknowns. A discussion of the cases is presented as if it were a consultation— with a description of the findings, differential diagnosis, and final diagnosis. A brief discussion of the disease is included. The end of each chapter lists differential diagnoses for the chapter's specific organ. Full-color composite anatomical illustrations show the immediately obvious appearance of common conditions that correlate with major radiologic findings.
Diagnosis and Excision of Subconjunctival Herniation of Orbital Fat
Skorin, Leonid , Rink, Caleb

Optometry and Vision Science | August 1, 2014 | Volume: 91 | Issue: 9 | Pages: No page available

10.1097/opx.0000000000000342 | PMID 25083836 Get It

ABSTRACT Purpose To present and discuss a case of herniation of subconjunctival orbital fat, a very rare but benign condition. Case Report An 84‐year‐old man presented to the eye clinic for a cataract surgery consultation but also had a secondary complaint about yellow lesions on the bulbar conjunctiva of both eyes. Examination with biomicroscopy revealed protruding orbital masses superotemporally in both eyes, with the right lesion being larger than the left. After thorough testing, these lesions were diagnosed as being subconjuntival herniated orbital fat (HOF), and the patient underwent surgical excision of the lesions. Conclusions In cases of HOF, appropriate and accurate testing is essential, as this condition can mimic several other neoplasms, all of which require specialized treatment strategies. If cosmesis is unacceptable to the patient or the lesion impedes normal ocular function, a subconjunctival excision of the excess fat may be performed with little concern of recurrence. This article discusses a case of HOF, with an explanation of testing and treatment options.
Periprocedural and mid-term technical and clinical events after flow diversion for intracranial aneurysms
Burrows, Anthony M. , Cloft, Harry J. , Kallmes, David F. , Cloft, Harry, Lanzino, Giuseppe

Journal of NeuroInterventional Surgery | August 1, 2014 | Volume: 7 | Issue: 9 | Pages: 646-651

10.1136/neurintsurg-2014-011184 | PMID 25082803 Get It

Object Flow diversion has emerged as a promising treatment alternative for cerebral aneurysms. As a new device, treatment-related events and complications are currently being characterized. Methods Data on 100 consecutive procedures with the intention to use flow diversion were prospectively collected and analyzed retrospectively. Results Ninety-five aneurysms were treated in 93 patients during 100 consecutive procedures in which the intention was to treat an intracranial aneurysm with flow diversion. Death occurred in 1% and permanent morbidity in 1%. However, periprocedural technical complications occurred in 35% of the procedures and included proximal device migration in 12%, incomplete device expansion in 9%, catheter-induced vasospasm in 6%, and artery perforation from the wire in 3%. Perioperative clinical events were seen in 28% (thromboembolism and access site complications were the most common, being observed in 6.5% of patients). Worsened extraocular motility was seen in 5.4% and resolved in 4/5 patients. Mean clinical follow-up was 17 months. There were no late clinical or technical issues resulting in permanent deficits, although one patient suffered worsening ataxia. Overall, using very strict angiographic criteria, complete angiographic obliteration was 50% at 6 months and 69% after 1 year. Conclusions Flow diversion for intracranial aneurysms is a safe and effective treatment. Technical and clinical events are common in the perioperative period. Careful perioperative care and proper management of technical and clinical events encountered is key to achieving low morbidity and mortality. Late clinical events can occur but are unlikely to result in permanent complications.
Promoter-proximal transcription factor binding is transcriptionally active when coupled with nucleosome repositioning in immediate vicinity
Yadav, Vinod Kumar , Thakur, Ram Krishna, Eckloff, Bruce W., Baral, Aradhita, Singh, Ankita, Halder, Rashi , Kumar, Akinchan, Alam, Mohammad P., Kundu, Tapas K. , Pandita, Raj K., Pandita, Tej K. , Wieben, Eric D. , Chowdhury, Shantanu , Eckloff, Bruce

Nucleic Acids Research | August 1, 2014 | Volume: 42 | Issue: 15 | Pages: 9602-9611

10.1093/nar/gku596 | PMID 25081206 Get It

Abstract Previous studies have analyzed patterns of transcription, transcription factor (TF) binding or mapped nucleosome occupancy across the genome. These suggest that the three aspects are genetically connected but the cause and effect relationships are still unknown. For example, physiologic TF binding studies involve many TFs, consequently, it is difficult to assign nucleosome reorganization to the binding site occupancy of any particular TF. Therefore, several aspects remain unclear: does TF binding influence nucleosome (re)organizations locally or impact the chromatin landscape at a more global level; are all or only a fraction of TF binding a result of reorganization in nucleosome occupancy and do all TF binding and associated changes in nucleosome occupancy result in altered gene expression? With these in mind, following characterization of two states (before and after induction of a single TF of choice) we determined: (i) genomic binding sites of the TF, (ii) promoter nucleosome occupancy and (iii) transcriptome profiles. Results demonstrated that promoter-proximal TF binding influenced expression of the target gene when it was coupled to nucleosome repositioning at or close to its binding site in most cases. In contrast, only in few cases change in target gene expression was found when TF binding occurred without local nucleosome reorganization.
Creating a Patient-Centered Health Care Delivery System
Mohammed, Khaled , Nolan, Margaret , Rajjo, Tamim , Shah, Nilay D. , Varkey, Prathibha, Murad, M. Hassan , Nolan, Margaret B, Murad, Mohammad H, Prokop, Larry J. , Murad, M Hassan , Nolan, Margaret B

American Journal of Medical Quality | August 1, 2014 | Volume: 31 | Issue: 1 | Pages: 12-21

10.1177/1062860614545124 | PMID 25082873 Get It

Faculty Opinions recommendation of How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature.
Coddington, Charles C.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | July 31, 2014 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718485950.793497799 Get It

Novel techniques for gastric variceal obliteration
Fujii‐Lau, Larissa L., Law, Ryan , Song, Louis M. Wong Kee , Levy, Michael J.

Digestive Endoscopy | July 31, 2014 | Volume: 27 | Issue: 2 | Pages: 189-196

10.1111/den.12337 | PMID 25079248 Get It

Acute hemorrhage related to gastric varices (GV) is more severe and often more difficult to immediately treat upon detection, leading to a poorer patient prognosis, as compared to esophageal variceal bleeding. Currently, the recommended treatment of bleeding GV is endoscopic cyanoacrylate injection and transjugular intrahepatic portosystemic shunt placement for endoscopic failures. Newer endoscopic (e.g. hemospray) and endosonographic (e.g. coil injection, glue obliteration, or combined coil and glue injection) techniques have been developed to offer an alternative treatment and improve patient outcome. The present article serves to review the endoscopic, endosonographic, and interventional radiological techniques used to treat GV and their clinical applications.
Endocytosis of collagen by hepatic stellate cells regulates extracellular matrix dynamics
Bi, Yan , Drinane, Mary , Ji, Baoan , Cao, Sheng , Shah, Vijay H. , Mukhopadhyay, Dhriti , Li, Xing

American Journal of Physiology-Cell Physiology | July 31, 2014 | Volume: 307 | Issue: 7 | Pages: C622-C633

10.1152/ajpcell.00086.2014 | PMID 25080486 Get It

Hepatic stellate cells (HSCs) generate matrix, which in turn may also regulate HSCs function during liver fibrosis. We hypothesized that HSCs may endocytose matrix proteins to sense and respond to changes in microenvironment. Primary human HSCs, LX2, or mouse embryonic fibroblasts (MEFs) [wild-type; c-abl−/−; or Yes, Src, and Fyn knockout mice (YSF−/−)] were incubated with fluorescent-labeled collagen or gelatin. Fluorescence-activated cell sorting analysis and confocal microscopy were used for measuring cellular internalization of matrix proteins. Targeted PCR array and quantitative real-time PCR were used to evaluate gene expression changes. HSCs and LX2 cells endocytose collagens in a concentration- and time-dependent manner. Endocytosed collagen colocalized with Dextran 10K, a marker of macropinocytosis, and 5-ethylisopropyl amiloride, an inhibitor of macropinocytosis, reduced collagen internalization by 46%. Cytochalasin D and ML7 blocked collagen internalization by 47% and 45%, respectively, indicating that actin and myosin are critical for collagen endocytosis. Wortmannin and AKT inhibitor blocked collagen internalization by 70% and 89%, respectively, indicating that matrix macropinocytosis requires phosphoinositide-3-kinase (PI3K)/AKT signaling. Overexpression of dominant-negative dynamin-2 K44A blocked matrix internalization by 77%, indicating a role for dynamin-2 in matrix macropinocytosis. Whereas c-abl−/− MEF showed impaired matrix endocytosis, YSF−/− MEF surprisingly showed increased matrix endocytosis. It was also associated with complex gene regulations that related with matrix dynamics, including increased matrix metalloproteinase 9 (MMP-9) mRNA levels and zymographic activity. HSCs endocytose matrix proteins through macropinocytosis that requires a signaling network composed of PI3K/AKT, dynamin-2, and c-abl. Interaction with extracellular matrix regulates matrix dynamics through modulating multiple gene expressions including MMP-9.
iPS Cell–Derived Cardiogenicity is Hindered by Sustained Integration of Reprogramming Transgenes
Martinez‐Fernandez, Almudena , Reyes, Santiago , Alekseev, Alexey E., Secreto, Frank J., Pérez-Terzic, Carmen, Beraldi, Rosanna, Sung, Hoon‐Ki , Nagy, András , Secreto, Frank, Nelson, Timothy J. , Terzic, André

Circulation: Cardiovascular Genetics | July 31, 2014 | Volume: 7 | Issue: 5 | Pages: 667-676

10.1161/circgenetics.113.000298 | PMID 25077947 Get It

Background—Nuclear reprogramming inculcates pluripotent capacity by which de novo tissue differentiation is enabled. Yet, introduction of ectopic reprogramming factors may desynchronize natural developmental schedules. This study aims to evaluate the effect of imposed transgene load on the cardiogenic competency of induced pluripotent stem (iPS) cells.Methods and Results—Targeted inclusion and exclusion of reprogramming transgenes (c-MYC,KLF4,OCT4, andSOX2) was achieved using a drug-inducible and removable cassette according to the piggyBac transposon/transposase system. Pulsed transgene overexpression, before iPS cell differentiation, hindered cardiogenic outcomes. Delayed in counterparts with maintained integrated transgenes, transgene removal enabled proficient differentiation of iPS cells into functional cardiac tissue. Transgene-free iPS cells generated reproducible beating activity with robust expression of cardiac α-actinin, connexin 43, myosin light chain 2a, α/β-myosin heavy chain, and troponin I. Although operational excitation–contraction coupling was demonstrable in the presence or absence of transgenes, factor-free derivatives exhibited an expedited maturing phenotype with canonical responsiveness to adrenergic stimulation.Conclusions—A disproportionate stemness load, caused by integrated transgenes, affects the cardiogenic competency of iPS cells. Offload of transgenes in engineered iPS cells ensures integrity of cardiac developmental programs, underscoring the value of nonintegrative nuclear reprogramming for derivation of competent cardiogenic regenerative biologics.